Novo Nordisk (NOVOB DC) CEO says the Co. sees positive early signs form high dose Wegovy UK launch, adding that the drug is on track for FDA approval in Q1
Importance
Level 1
#NOVO NORDISK A/S#NOVOB.DC#FDA#EU SESSION#EUROPEAN EQUITIES
© 2026 Newsquawk. All rights reserved.